Literature DB >> 28178051

Urinary Microbiome and Cytokine Levels in Women With Interstitial Cystitis.

Melinda G Abernethy1, Amy Rosenfeld, James R White, Margaret G Mueller, Christina Lewicky-Gaupp, Kimberly Kenton.   

Abstract

OBJECTIVE: To investigate differences in the urinary microbiome and cytokine levels between women with and without interstitial cystitis and to correlate differences with scores on standardized symptom severity scales and depression and anxiety screening tools.
METHODS: Our cross-sectional study compared women presenting to a pelvic floor clinic and diagnosed with interstitial cystitis over a 6-month period with age-matched women in a control group from the same institution. Participants provided a catheterized urine sample and completed symptom severity, quality-of-life, depression, and anxiety screening questionnaires. Urinary microbiomes generated through bacterial ribosomal RNA sequencing and cytokine levels were analyzed using a standard immunoassay. Nonparametric analyses were used for all comparisons.
RESULTS: Participants with interstitial cystitis reported more disability, bothersome urinary symptoms, genitourinary pain, and sexual dysfunction and scored higher on depression and anxiety screens compared with women in the control group. The urine of participants with interstitial cystitis contained fewer distinct operational taxonomic units (2 [median range 2-7, interquartile range 1] compared with 3.5 [median, range 2-22, interquartile range 5.25], P=.015) and was less likely to contain Lactobacillus acidophilus (1/14 [7%] compared with 7/18 [39%], P=.05) compared with women in the control group. L acidophilus was associated with less severe scores on the Interstitial Cystitis Symptoms Index (1 [median, range 0-17, interquartile range 5] compared with 10 [median, range 0-14, interquartile range 11], P=.005) and the Genitourinary Pain Index (0 [median, range 0-42, interquartile range 22] compared with 22.5 [median, range 0-40, interquartile range 28], P=.03). Participants with interstitial cystitis demonstrated higher levels of macrophage-derived chemokine (13.32 [median, range 8.93-17.05, interquartile range 15.86] compared with 0 [median, range 8.93-22.67, interquartile range 10.35], P=.037) and interleukin-4 (1.95 [median, range 1.31-997, interquartile range 11.84] compared with 1.17 [median, range 0.44-3.26, interquartile range 1.51], P=.029). There was a positive correlation between interleukin-4 and more severe scores on the Interstitial Cystitis Symptoms Index (r=0.406, P=.013). No associations between the presence of lactobacillus species and cytokine levels were observed.
CONCLUSION: The urinary microbiome of participants with interstitial cystitis was less diverse, less likely to contain Lactobacillus species, and associated with higher levels of proinflammatory cytokines. It is unknown whether this represents causality and whether the effect of alterations to the urinary microbiome is mediated through an inflammatory response.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28178051     DOI: 10.1097/AOG.0000000000001892

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  41 in total

Review 1.  Utility of DNA Next-Generation Sequencing and Expanded Quantitative Urine Culture in Diagnosis and Management of Chronic or Persistent Lower Urinary Tract Symptoms.

Authors:  Monika Gasiorek; Michael H Hsieh; Catherine S Forster
Journal:  J Clin Microbiol       Date:  2019-12-23       Impact factor: 5.948

Review 2.  Microbiota: a novel regulator of pain.

Authors:  Manon Defaye; Sandie Gervason; Christophe Altier; Jean-Yves Berthon; Denis Ardid; Edith Filaire; Frédéric Antonio Carvalho
Journal:  J Neural Transm (Vienna)       Date:  2019-09-24       Impact factor: 3.575

3.  The impact of microbiome in urological diseases: a systematic review.

Authors:  Joseph K M Li; Peter K F Chiu; Chi-Fai Ng
Journal:  Int Urol Nephrol       Date:  2019-07-12       Impact factor: 2.370

Review 4.  [The role of the microbiome in urology].

Authors:  G Magistro; J Marcon; L Eismann; Y Volz; C G Stief
Journal:  Urologe A       Date:  2020-12       Impact factor: 0.639

5.  Pain: Changes in urinary microbiota correlate with IC/BPS.

Authors:  Peter Sidaway
Journal:  Nat Rev Urol       Date:  2017-03-01       Impact factor: 14.432

Review 6.  Urologic chronic pelvic pain syndrome: insights from the MAPP Research Network.

Authors:  J Quentin Clemens; Chris Mullins; A Lenore Ackerman; Tamara Bavendam; Adrie van Bokhoven; Benjamin M Ellingson; Steven E Harte; Jason J Kutch; H Henry Lai; Katherine T Martucci; Robert Moldwin; Bruce D Naliboff; Michel A Pontari; Siobhan Sutcliffe; J Richard Landis
Journal:  Nat Rev Urol       Date:  2019-03       Impact factor: 14.432

Review 7.  Community profiling of the urinary microbiota: considerations for low-biomass samples.

Authors:  Lisa Karstens; Mark Asquith; Vincent Caruso; James T Rosenbaum; Damien A Fair; Jonathan Braun; W Thomas Gregory; Rahel Nardos; Shannon K McWeeney
Journal:  Nat Rev Urol       Date:  2018-12       Impact factor: 14.432

8.  Profiling the Urinary Microbiome in Men with Positive versus Negative Biopsies for Prostate Cancer.

Authors:  Eva Shrestha; James R White; Shu-Han Yu; Ibrahim Kulac; Onur Ertunc; Angelo M De Marzo; Srinivasan Yegnasubramanian; Leslie A Mangold; Alan W Partin; Karen S Sfanos
Journal:  J Urol       Date:  2017-08-07       Impact factor: 7.450

9.  Female lower urinary tract microbiota do not associate with IC/PBS symptoms: a case-controlled study.

Authors:  Larissa Bresler; Travis K Price; Evann E Hilt; Cara Joyce; Colleen M Fitzgerald; Alan J Wolfe
Journal:  Int Urogynecol J       Date:  2019-04-16       Impact factor: 2.894

Review 10.  Interstitial cystitis/bladder pain syndrome: The evolving landscape, animal models and future perspectives.

Authors:  Yoshiyuki Akiyama; Yi Luo; Philip M Hanno; Daichi Maeda; Yukio Homma
Journal:  Int J Urol       Date:  2020-04-04       Impact factor: 3.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.